Kherion Technology
Kherion Technology is a privately held biotechnology company headquartered in Cambridge, U.K., focusing on immunotherapy treatments for autoimmunity and cancer. The company works on improving treatment efficacy and patient safety while reducing adverse side effects compared to existing pharmaceutical products.
- Cancer immunotherapy treatments
- Immunotherapy treatments for autoimmune diseases
- Proprietary compounds for immune system modulation
Locations
Digital Popularity
Social Media
Competitors
ET-traps Limited is a pharmaceutical company focused on developing novel therapeutics that target pathologically elevated endothelin-1 levels in the body.
AstraZeneca is a research-based bio-pharmaceutical company that focuses on the discovery, development, and commercialisation of innovative medicines.
Company Details
Kherion Technology is operated by Kherion Technology Limited and is a Active company incorporated on 19 August 2003 with the registered office located in Cambridge, Cambridgeshire. Kherion Technology Limited was registered 22 years ago.
Status
Active
Size
Micro
Directors
2
Age
22 years old
Employees
1
Turnover
Unreported
Total Assets
£6.45K
Cash in Bank
Unreported
Total Liabilities
-£254.22K